184 related articles for article (PubMed ID: 37992141)
21. Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort.
Gomes N; Huynh A; Borel C; Guenounou S; Recher C; Barres B; Vigarios E; Sibaud V
Oral Oncol; 2021 Mar; 114():105082. PubMed ID: 33187825
[TBL] [Abstract][Full Text] [Related]
22. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
[TBL] [Abstract][Full Text] [Related]
23. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
24. Aggressive conjunctival carcinoma arising on poorly controlled sun-damaged graft-versus-host disease.
Konishi R; Ishitsuka Y; Inoue S; Saito A; Nakamura Y; Watanabe R; Okiyama N; Chiba S; Nishikii H; Fujimoto M; Fujisawa Y
Eur J Dermatol; 2020 Jun; 30(3):313-314. PubMed ID: 32666932
[No Abstract] [Full Text] [Related]
25. A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation.
Tsushima F; Sakurai J; Harada H
Aust Dent J; 2015 Sep; 60(3):404-7. PubMed ID: 26211810
[TBL] [Abstract][Full Text] [Related]
26. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.
Curtis RE; Metayer C; Rizzo JD; Socié G; Sobocinski KA; Flowers ME; Travis WD; Travis LB; Horowitz MM; Deeg HJ
Blood; 2005 May; 105(10):3802-11. PubMed ID: 15687239
[TBL] [Abstract][Full Text] [Related]
27. Acute graft versus host disease in hematopoietic stem cell alotransplant recipients.
Krstevska S; Genadieva-Stavric S; Pivkova A; Stojanovski Z; Georgievski B; Balkanov T
Med Arh; 2011; 65(5):260-4. PubMed ID: 22073847
[TBL] [Abstract][Full Text] [Related]
28. Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Wegener A; Andersen NS; Friis LS; Petersen SL; Schjødt I; Kornblit B; Sengeløv H; Gjærde LK
Transplant Cell Ther; 2023 Sep; 29(9):575.e1-575.e6. PubMed ID: 37301257
[TBL] [Abstract][Full Text] [Related]
29. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Wu T; Liu Z; Yong X; Mei G; Jiang Q; Fang M; Li P; Zhang Z; Tao R
Oral Oncol; 2021 Oct; 121():105399. PubMed ID: 34217620
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
31. Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center.
Scaraficci AC; Fernandes PM; Abreu Alves F; Filho JS; Jaguar GC
Support Care Cancer; 2022 Jan; 30(1):567-573. PubMed ID: 34341851
[TBL] [Abstract][Full Text] [Related]
32. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.
Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC
Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110
[TBL] [Abstract][Full Text] [Related]
33. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
Zhao L; Chen S; Yang P; Cao H; Li L
Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
[TBL] [Abstract][Full Text] [Related]
34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
36. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
37. [Two cases of malignant tumors of the face after hematopoietic stem cell transplantation].
Girod A; Breton P
Rev Stomatol Chir Maxillofac; 2005 Apr; 106(2):107-10. PubMed ID: 15924098
[TBL] [Abstract][Full Text] [Related]
38. Fanconi anemia and hematopoietic stem cell transplant as risk factors for oral squamous cell carcinoma: A case report with a 12-year follow-up.
Macedo LFDSL; Domaneschi C; Miguita Luiz L; Peres MPSM; Franco JB
Spec Care Dentist; 2022 May; 42(3):299-303. PubMed ID: 34735020
[TBL] [Abstract][Full Text] [Related]
39. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Mielcarek M; Martin PJ; Leisenring W; Flowers ME; Maloney DG; Sandmaier BM; Maris MB; Storb R
Blood; 2003 Jul; 102(2):756-62. PubMed ID: 12663454
[TBL] [Abstract][Full Text] [Related]
40. Oral nutritional support to adult patients with acute intestinal Graft Versus Host Disease (GVHD): A proposal for dietary intervention as a model to clinical trials.
Chiconato GC; Campos DJ; Thomaz AC; Moreira Funke VA; Vilela RM
Clin Nutr ESPEN; 2020 Dec; 40():369-375. PubMed ID: 33183565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
